To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene HNRNPA2B1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
689 representative clones for gene HNRNPA2B1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA163093 amygdala .a 1 to 570 2 to 571   tiling clone, capped   570/570
(100 %)
0 diff
(100 %id)
NM_031243.2   .a 3 to 3704 1 to 3702 exact RefSeq,   3702/3702
(100 %)
0 diff
(100 %id)
DA823232 pericardium .a 13 to 572 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA256030 caudate nucleus .a 14 to 563 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
BU146568 brain, neuroblastoma, cell line .a 19 to 829 1 to 816       816/893
(91 %)
6 diff
(99.4 %id)
DA129164 alzheimer cortex .a 22 to 471 2 to 451   capped   450/450
(100 %)
0 diff
(100 %id)
DA846692 placenta .a 22 to 597 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA899629 skeletal muscle .a 22 to 588 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA388094 thalamus .a 23 to 512 2 to 491   capped   490/490
(100 %)
0 diff
(100 %id)
DA737377.
matches multiple genes
  .a 23 to 871 2 to 852   capped also hits gene DYNC1I1 851/851
(100 %)
3 diff
(99.7 %id)
DA164271 amygdala .a 24 to 595 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA662858   .a 24 to 529 2 to 507   capped   506/506
(100 %)
0 diff
(100 %id)
DA826962 pericardium .a 49 to 610 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
AK289429   .a 50 to 1625 1 to 1576 G205S     1576/1576
(100 %)
1 diff
(100.0 %id)
DA037583   .a 51 to 601 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA068844 cerebellum .a 51 to 388 2 to 339   capped   338/338
(100 %)
0 diff
(100 %id)
DA103957 cerebellum .a 51 to 387 2 to 338   capped   337/337
(100 %)
0 diff
(100 %id)
DA128228 cerebellum .a 51 to 631 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA629550 Kidney .a 51 to 624 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA819631   .a 51 to 608 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA824235 pericardium .a 51 to 625 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA892492 rectum .a 51 to 612 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA896812 skeletal muscle .a 51 to 614 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA983407 synovial membrane tissue from rheumatioidarthritis .a 51 to 544 2 to 495   capped   494/494
(100 %)
0 diff
(100 %id)
DB031497 testis .a 51 to 665 2 to 616   capped   615/615
(100 %)
0 diff
(100 %id)
DB194222 ovary, tumor tissue .a 51 to 439 2 to 390   capped   389/389
(100 %)
0 diff
(100 %id)
M29064   .a 70 to 1793 1 to 1724 exact tiling clone, AAA   1724/1724
(100 %)
0 diff
(100 %id)
AV703663 adrenal gland .a 85 to 496 1 to 412       412/412
(100 %)
0 diff
(100 %id)
CN262856 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 304 to 795 1 to 492       492/492
(100 %)
0 diff
(100 %id)
DA566979 heart .a 399 to 726 2 to 329   capped   328/328
(100 %)
0 diff
(100 %id)
BI063903 uterus_tumor .a 417 to 955 539 to 1       539/539
(100 %)
0 diff
(100 %id)
BI039064 nervous_tumor .a 427 to 826 400 to 1       400/400
(100 %)
0 diff
(100 %id)
FN054589 breast carcinoma .a 457 to 554 98 to 1     Submitted on the opposite strand 98/98
(100 %)
0 diff
(100 %id)
CN262879 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 582 to 897 1 to 316       316/316
(100 %)
0 diff
(100 %id)
CR996731 T-Lymphocytes .a 588 to 1248 1 to 661       661/664
(99 %)
1 diff
(99.9 %id)
CR999468 T-Lymphocytes .a 588 to 1321 1 to 734       734/736
(99 %)
1 diff
(99.9 %id)
CN262829 embryonic stem cells, DMSO-treated H9 cellline .a 678 to 1235 1 to 558       558/558
(100 %)
0 diff
(100 %id)
CN262896 embryonic stem cells, DMSO-treated H9 cellline .a 694 to 1446 1 to 753       753/753
(100 %)
0 diff
(100 %id)
CB122545 Liver .a 707 to 1231 1 to 525       525/525
(100 %)
0 diff
(100 %id)
CR613897 thymus .a 761 to 1519 1 to 759       759/759
(100 %)
0 diff
(100 %id)
BX456448 thymus .a 761 to 1519 1 to 757       757/757
(100 %)
2 diff
(99.8 %id)
BM905910 leiomyosarcoma, uterus .a 764 to 1757 1 to 1006       1006/1032
(97 %)
26 diff
(97.5 %id)
CN262850 embryonic stem cells, DMSO-treated H9 cellline .a 776 to 1391 1 to 616       616/616
(100 %)
0 diff
(100 %id)
CN262838 embryonic stem cells, DMSO-treated H9 cellline .a 778 to 1328 1 to 551       551/551
(100 %)
0 diff
(100 %id)
BI093432 cervix .a 790 to 1641 1 to 864       864/864
(100 %)
29 diff
(96.7 %id)
DA269016 caudate nucleus .a 791 to 1287 2 to 498   capped   497/497
(100 %)
0 diff
(100 %id)
BG403124 bladder, transitional cell papilloma, cell line .a 804 to 1549 1 to 749       749/934
(80 %)
9 diff
(99.1 %id)
CN262900 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 813 to 1436 1 to 624       624/624
(100 %)
0 diff
(100 %id)
CN262861 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 817 to 1267 1 to 451       451/451
(100 %)
0 diff
(100 %id)
BU599684 mixed (pool of 40 RNAs) .a 822 to 1574 2 to 763       762/813
(93 %)
15 diff
(98.2 %id)
BQ439552 large cell carcinoma, lung .a 824 to 1557 1 to 743       743/923
(80 %)
18 diff
(98.1 %id)
BQ216618 large cell carcinoma, lung .a 850 to 1683 1 to 847       847/895
(94 %)
32 diff
(96.5 %id)
FN173930 breast carcinoma .a 872 to 978 107 to 1     Submitted on the opposite strand 107/107
(100 %)
0 diff
(100 %id)
CN262877 embryonic stem cells, cell lines H1, H7, andH9 .a 909 to 1116 1 to 208       208/208
(100 %)
0 diff
(100 %id)
BU175490 embryonal carcinoma, cell line, testis .a 911 to 1793 1 to 890   AAA   890/890
(100 %)
13 diff
(98.6 %id)
CN262887 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 921 to 1492 1 to 572       572/572
(100 %)
0 diff
(100 %id)
BU178778 eye, retinoblastoma .a 943 to 1793 1 to 866       866/974
(88 %)
18 diff
(98.2 %id)
BG955076 colon .a 946 to 1050 1 to 105       105/105
(100 %)
0 diff
(100 %id)
BU189057 melanotic melanoma, skin .a 948 to 1742 1 to 798       798/829
(96 %)
9 diff
(99.0 %id)
CD721803 eye, lacrimal gland .a 963 to 1587 1 to 625       625/625
(100 %)
0 diff
(100 %id)
CN262859 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 974 to 1681 22 to 730       709/730
(97 %)
7 diff
(99.1 %id)
TI_149285471   .a 1006 to 1793 873 to 97   AAA   777/1118
(69 %)
15 diff
(98.7 %id)
CN262899 embryonic stem cells, cell lines H1, H7, andH9 .a 1010 to 1157 1 to 148       148/148
(100 %)
0 diff
(100 %id)
CN262845 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1011 to 1735 1 to 726       726/726
(100 %)
1 diff
(99.9 %id)
FN048049 breast carcinoma .a 1014 to 1120 1 to 107       107/107
(100 %)
0 diff
(100 %id)
BU074216 insulinoma, Pancreas .a 1017 to 1552 1 to 536     Submitted on the opposite strand 536/536
(100 %)
0 diff
(100 %id)
BM795884 Ascites, stomach .a 1020 to 1421 1 to 402       402/402
(100 %)
0 diff
(100 %id)
AA380066 skin .a 1021 to 1325 1 to 305       305/305
(100 %)
0 diff
(100 %id)
BM823294 Ascites, stomach .a 1021 to 1498 1 to 478       478/478
(100 %)
0 diff
(100 %id)
TI_149285140   .a 1042 to 1793 850 to 98   AAA   753/1079
(69 %)
3 diff
(99.8 %id)
TI_154060088   .a 1045 to 1793 823 to 84   AAA   742/953
(77 %)
15 diff
(98.5 %id)
CN262826 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1050 to 1737 1 to 688       688/688
(100 %)
1 diff
(99.9 %id)
CN262852 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1057 to 1734 1 to 678       678/678
(100 %)
0 diff
(100 %id)
BI004335 head_normal .a 1066 to 1186 1 to 121       121/121
(100 %)
0 diff
(100 %id)
DR155579 human embryonic stem cells differentiated toan early endodermal cell type .a 1067 to 1268 1 to 202       202/202
(100 %)
0 diff
(100 %id)
AW999679 breast_normal .a 1080 to 1182 1 to 103       103/103
(100 %)
0 diff
(100 %id)
CN262858 embryonic stem cells, cell lines H1, H7, andH9 .a 1091 to 1574 1 to 484       484/484
(100 %)
0 diff
(100 %id)
FN162995 breast carcinoma .a 1094 to 1213 119 to 1     Submitted on the opposite strand 119/121
(98 %)
3 diff
(97.6 %id)
TI_227713761   .a 1094 to 1793 779 to 83   AAA   697/976
(71 %)
4 diff
(99.6 %id)
BY795496 eye .a 1095 to 1599 1 to 505       505/505
(100 %)
0 diff
(100 %id)
FN088576 breast carcinoma .a 1096 to 1161 66 to 1     Submitted on the opposite strand 66/66
(100 %)
1 diff
(98.5 %id)
CB160971 Liver .a 1099 to 1644 1 to 546       546/546
(100 %)
0 diff
(100 %id)
TI_227712393   .a 1103 to 1793 781 to 91   AAA   691/968
(71 %)
0 diff
(100 %id)
BU532955 mixed (pool of 40 RNAs) .a 1104 to 1795 1 to 692       692/784
(88 %)
5 diff
(99.4 %id)
AA380242 skin .a 1111 to 1320 1 to 210       210/210
(100 %)
0 diff
(100 %id)
TI_149271996   .a 1111 to 1793 801 to 123   AAA   681/961
(70 %)
8 diff
(99.2 %id)
CN262897 embryonic stem cells, DMSO-treated H9 cellline .a 1112 to 1337 1 to 226       226/226
(100 %)
0 diff
(100 %id)
FN065460 breast carcinoma .a 1113 to 1196 83 to 1     Submitted on the opposite strand 83/102
(81 %)
2 diff
(98.1 %id)
BP419431 small intestine .a 1120 to 1606 1 to 487     Submitted on the opposite strand 487/487
(100 %)
0 diff
(100 %id)
TI_149299551   .a 1121 to 1793 762 to 90   AAA   673/987
(68 %)
0 diff
(100 %id)
BM975864 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1121 to 1793 691 to 19   AAA   673/681
(98 %)
0 diff
(100 %id)
BQ001368 lung, Metastatic Chondrosarcoma .a 1125 to 1793 687 to 19   AAA   669/683
(97 %)
0 diff
(100 %id)
AA361758   .a 1127 to 1309 1 to 183       183/183
(100 %)
0 diff
(100 %id)
BM997721 lung, Metastatic Chondrosarcoma .a 1131 to 1793 681 to 19   AAA   663/663
(100 %)
1 diff
(99.9 %id)
BU680780 lung .a 1137 to 1793 675 to 19   AAA   657/657
(100 %)
0 diff
(100 %id)
TI_149277979   .a 1139 to 1793 740 to 89   AAA   652/696
(93 %)
3 diff
(99.6 %id)
BQ631360 Pancreas, Purified pancreatic islet .a 1146 to 1793 659 to 12   AAA   648/648
(100 %)
0 diff
(100 %id)
BU678124 lung .a 1147 to 1793 662 to 19   AAA   644/644
(100 %)
3 diff
(99.6 %id)
CA432534 cell lines, Chondrosarcoma .a 1149 to 1793 663 to 19   AAA   645/645
(100 %)
0 diff
(100 %id)
BG575675 breast, mammary adenocarcinoma, cell line .a 1154 to 1784 1 to 631       631/631
(100 %)
0 diff
(100 %id)
BQ014176 Chondrosarcoma, Left Pubic Bone .a 1154 to 1793 658 to 19   AAA   640/640
(100 %)
0 diff
(100 %id)
BU625077 cell lines, Enchondroma .a 1156 to 1792 651 to 15   AAA   637/637
(100 %)
0 diff
(100 %id)
AW007724 thymus, pooled .a 1158 to 1794 637 to 1       637/637
(100 %)
0 diff
(100 %id)
BQ573857 Chondrosarcoma Grade II, Left Pelvis .a 1158 to 1793 651 to 19   AAA   633/655
(96 %)
4 diff
(99.4 %id)
BM795348 Ascites, stomach .a 1161 to 1550 1 to 390       390/390
(100 %)
0 diff
(100 %id)
CA442031 lung, Metastatic Chondrosarcoma .a 1162 to 1792 642 to 15   AAA   628/628
(100 %)
3 diff
(99.6 %id)
BQ771984 Chondrosarcoma Grade II, Left Pelvis .a 1162 to 1793 649 to 19   AAA   631/631
(100 %)
1 diff
(99.9 %id)
BM990387 lung, Metastatic Chondrosarcoma .a 1164 to 1793 648 to 19   AAA   630/630
(100 %)
0 diff
(100 %id)
BM996201 lung, Metastatic Chondrosarcoma .a 1165 to 1793 644 to 19   AAA   626/626
(100 %)
3 diff
(99.6 %id)
BQ574155 Chondrosarcoma Grade II, Left Pelvis .a 1166 to 1793 646 to 19   AAA   628/628
(100 %)
0 diff
(100 %id)
CN262846 embryonic stem cells, DMSO-treated H9 cellline .a 1167 to 1796 1 to 630       630/632
(99 %)
1 diff
(99.9 %id)
BQ000842 lung, Metastatic Chondrosarcoma .a 1171 to 1793 640 to 19   AAA   622/622
(100 %)
2 diff
(99.7 %id)
AA355521   .a 1173 to 1494 1 to 322       322/322
(100 %)
0 diff
(100 %id)
TI_149278090   .a 1189 to 1793 708 to 104   AAA   605/693
(87 %)
0 diff
(100 %id)
BU678210 lung .a 1189 to 1793 623 to 19   AAA   605/620
(97 %)
0 diff
(100 %id)
BF915869 uterus_tumor .a 1192 to 1441 250 to 1     Submitted on the opposite strand 250/250
(100 %)
0 diff
(100 %id)
BM681616 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1199 to 1793 613 to 19   AAA   595/604
(98 %)
0 diff
(100 %id)
AA330938 embryo .a 1219 to 1421 1 to 203       203/203
(100 %)
0 diff
(100 %id)
BX438636 neuroblastoma .a 1219 to 1796 1 to 578       578/578
(100 %)
0 diff
(100 %id)
AA380005 skin .a 1247 to 1490 1 to 244       244/244
(100 %)
0 diff
(100 %id)
BF940707 fibrotheoma, ovary .a 1252 to 1795 544 to 1       544/544
(100 %)
0 diff
(100 %id)
BF939566 brain, glioblastoma (pooled) .a 1265 to 1788 524 to 1       524/524
(100 %)
0 diff
(100 %id)
BG032064 breast, mammary adenocarcinoma, cell line .a 1267 to 1793 1 to 527   AAA   527/527
(100 %)
0 diff
(100 %id)
CN262825 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1270 to 1793 7 to 530       524/530
(98 %)
6 diff
(98.9 %id)
AV687907 hepatocellular carcinoma .a 1270 to 1793 1 to 524   AAA   524/524
(100 %)
0 diff
(100 %id)
BM984892 lung .a 1272 to 1793 540 to 19   AAA   522/522
(100 %)
0 diff
(100 %id)
AI160059 heart .a 1285 to 1793 538 to 30   AAA   509/509
(100 %)
0 diff
(100 %id)
AA453200   .a 1302 to 1789 1 to 488       488/488
(100 %)
0 diff
(100 %id)
BF590114 pooled .a 1309 to 1793 497 to 13   AAA   485/485
(100 %)
0 diff
(100 %id)
AA702093 pineal gland .a 1310 to 1793 484 to 1       484/484
(100 %)
0 diff
(100 %id)
BI496216 cochlea, ear .a 1311 to 1793 519 to 37   AAA   483/483
(100 %)
0 diff
(100 %id)
AJ709140 heart .a 1314 to 1793 1 to 480   AAA   480/480
(100 %)
0 diff
(100 %id)
BI019907 marrow .a 1316 to 1490 1 to 175       175/175
(100 %)
0 diff
(100 %id)
AI475739 B-cell, chronic lymphotic leukemia .a 1319 to 1794 476 to 1       476/476
(100 %)
0 diff
(100 %id)
R29188   .a 1327 to 1442 1 to 116       116/116
(100 %)
0 diff
(100 %id)
BE646034 Prostate .a 1329 to 1793 465 to 1       465/465
(100 %)
0 diff
(100 %id)
AI690264 carcinoid, lung .a 1335 to 1792 458 to 1       458/458
(100 %)
0 diff
(100 %id)
AA089571   .a 1339 to 1510 1 to 172       172/172
(100 %)
0 diff
(100 %id)
AI625940 colon .a 1343 to 1788 446 to 1       446/446
(100 %)
0 diff
(100 %id)
N68529 lung .a 1351 to 1794 444 to 1       444/444
(100 %)
0 diff
(100 %id)
AI348671 carcinoid, lung .a 1368 to 1793 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AA505251 breast .a 1383 to 1796 414 to 1       414/414
(100 %)
0 diff
(100 %id)
CN262868 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1388 to 1774 1 to 387       387/387
(100 %)
0 diff
(100 %id)
CV571497 cornea, eye .a 1392 to 1793 1 to 402   AAA   402/402
(100 %)
0 diff
(100 %id)
AA968979 Kidney, kidney tumor .a 1394 to 1733 340 to 1       340/340
(100 %)
0 diff
(100 %id)
BQ232522 melanotic melanoma, skin .a 1398 to 1793 1 to 396   AAA   396/396
(100 %)
0 diff
(100 %id)
D57780   .a 1400 to 1642 1 to 243       243/243
(100 %)
0 diff
(100 %id)
BE000032 breast_normal .a 1402 to 1738 1 to 337       337/337
(100 %)
0 diff
(100 %id)
BM455855 lymph, lymphoma, cell line .a 1409 to 1788 1 to 380   AAA   380/380
(100 %)
0 diff
(100 %id)
AA962557 Kidney .a 1428 to 1792 365 to 1       365/365
(100 %)
0 diff
(100 %id)
T28569 Spleen .a 1437 to 1793 357 to 1       357/357
(100 %)
0 diff
(100 %id)
AI267864 carcinoid, lung .a 1452 to 1796 345 to 1       345/345
(100 %)
0 diff
(100 %id)
CN262813 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1453 to 2082 1 to 631       631/631
(100 %)
1 diff
(99.9 %id)
BX431576 brain, fetal brain .a 1463 to 2382 1 to 931       931/940
(99 %)
29 diff
(97.0 %id)
BF446246 Prostate .a 1508 to 1796 289 to 1       289/289
(100 %)
0 diff
(100 %id)
AI581726 aorta .a 1534 to 1788 255 to 1       255/255
(100 %)
0 diff
(100 %id)
CN262830 embryonic stem cells, DMSO-treated H9 cellline .a 1538 to 2238 1 to 701       701/701
(100 %)
1 diff
(99.9 %id)
D53192   .a 1542 to 1793 1 to 252       252/252
(100 %)
0 diff
(100 %id)
AA703571 liver and spleen .a 1553 to 1721 169 to 1       169/169
(100 %)
0 diff
(100 %id)
CN262815 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1608 to 2261 1 to 655       655/655
(100 %)
1 diff
(99.9 %id)
CB108893 Liver .a 1610 to 1783 1 to 174       174/174
(100 %)
0 diff
(100 %id)
CD724177 eye, lacrimal gland .a 1621 to 1793 1 to 173   AAA   173/173
(100 %)
0 diff
(100 %id)
CD724181 eye, lacrimal gland .a 1621 to 1793 1 to 173   AAA   173/173
(100 %)
0 diff
(100 %id)
CN262806 embryonic stem cells, DMSO-treated H9 cellline .a 1653 to 1898 1 to 246       246/246
(100 %)
0 diff
(100 %id)
AW059810   .a 1686 to 1793 1 to 108       108/108
(100 %)
0 diff
(100 %id)
BM739389 Ascites, stomach .a 1690 to 1793 1 to 104   AAA   104/104
(100 %)
0 diff
(100 %id)
BG110356 Bone, osteosarcoma, cell line .a 1722 to 2455 1 to 730   tiling clone,   730/735
(99 %)
10 diff
(98.7 %id)
F12801 brain, total brain .a 1760 to 2068 1 to 309       309/309
(100 %)
0 diff
(100 %id)
BP421508 small intestine .a 1856 to 2371 1 to 516     Submitted on the opposite strand 516/516
(100 %)
0 diff
(100 %id)
AK026373 human small intestine .a 1911 to 3328 1 to 1418   available from FLJ, AAA   1418/1418
(100 %)
2 diff
(99.9 %id)
W17019 lung .a 2011 to 2302 1 to 292       292/292
(100 %)
0 diff
(100 %id)
BG108429 Bone, osteosarcoma, cell line .a 2245 to 2981 1 to 735   tiling clone,   735/737
(99 %)
14 diff
(98.2 %id)
T24609   .a 2284 to 2409 1 to 126       126/126
(100 %)
0 diff
(100 %id)
BF110020 carcinoid, lung .a 2439 to 2628 1 to 190     Submitted on the opposite strand 190/190
(100 %)
0 diff
(100 %id)
H27061 breast .a 2441 to 2876 1 to 436       436/436
(100 %)
0 diff
(100 %id)
AA427526 ovarian tumor, ovary .a 2441 to 2863 1 to 423     Submitted on the opposite strand 423/423
(100 %)
0 diff
(100 %id)
AA909840 carcinoid, lung .a 2446 to 2945 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
AW612693 carcinoid, lung .a 2604 to 2971 1 to 368     Submitted on the opposite strand 368/368
(100 %)
0 diff
(100 %id)
BU629591 cell lines, Chondrosarcoma .a 2625 to 3333 727 to 19   tiling clone, AAA   709/709
(100 %)
0 diff
(100 %id)
AA479223.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2626 to 3040 1 to 415     also hits gene KDM1B 415/415
(100 %)
0 diff
(100 %id)
BP418420 small intestine .a 2659 to 3118 1 to 460     Submitted on the opposite strand 460/469
(98 %)
1 diff
(99.8 %id)
BQ008839 Chondrosarcoma, Left Pelvis .a 2773 to 3512 758 to 19   AAA   740/740
(100 %)
1 diff
(99.9 %id)
CA414671 Chondrosarcoma Grade II, Left Pelvis .a 2785 to 3512 746 to 19   AAA   728/728
(100 %)
2 diff
(99.8 %id)
TI_149301027   .a 2819 to 3703 955 to 81   tiling clone, AAA   875/1003
(87 %)
29 diff
(97.2 %id)
BQ029735 lung, Metastatic Chondrosarcoma .a 2906 to 3512 626 to 19   AAA   608/608
(100 %)
2 diff
(99.7 %id)
AI186661 lung .a 2993 to 3511 519 to 1       519/519
(100 %)
0 diff
(100 %id)
BE349459 malignant melanoma, metastatic to lymphnode, skin .a 3003 to 3512 510 to 1       510/510
(100 %)
0 diff
(100 %id)
AW471350 adenocarcinoma, Pancreas .a 3006 to 3513 508 to 1       508/508
(100 %)
0 diff
(100 %id)
BF109471 pooled .a 3006 to 3511 506 to 1       506/506
(100 %)
0 diff
(100 %id)
AW168028 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3044 to 3512 469 to 1       469/469
(100 %)
0 diff
(100 %id)
AI346563 adenocarcinoma, colon .a 3048 to 3512 465 to 1       465/465
(100 %)
0 diff
(100 %id)
AA479068.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3095 to 3515 421 to 1     also hits gene MDH1 421/421
(100 %)
0 diff
(100 %id)
AW614938 2 pooled high-grade transitional celltumors, genitourinary tract .a 3129 to 3512 396 to 13   AAA   384/384
(100 %)
0 diff
(100 %id)
F11075 brain, total brain .a 3199 to 3512 314 to 1       314/314
(100 %)
0 diff
(100 %id)
D61736   .a 3211 to 3476 1 to 266       266/266
(100 %)
0 diff
(100 %id)
AI566594 adenocarcinoma, Pancreas .a 3233 to 3514 282 to 1       282/282
(100 %)
0 diff
(100 %id)
AI280761 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 3255 to 3512 270 to 13   AAA   258/258
(100 %)
0 diff
(100 %id)
CF528416 placenta .a 3256 to 3512 274 to 18   AAA   257/257
(100 %)
0 diff
(100 %id)
AI932870 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3260 to 3513 254 to 1       254/254
(100 %)
0 diff
(100 %id)
AV707420 adrenal gland .a 3319 to 3512 1 to 194   AAA   194/194
(100 %)
0 diff
(100 %id)
CA415130 Chondrosarcoma Grade II, Left Pelvis .a 3325 to 3512 206 to 19   AAA   188/188
(100 %)
0 diff
(100 %id)
AI915452 ovary, tumor, 5 pooled (see description) .a 3408 to 3512 122 to 18   AAA   105/105
(100 %)
0 diff
(100 %id)
AI570298 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3420 to 3512 116 to 24   AAA   93/93
(100 %)
0 diff
(100 %id)
DB056933 testis .b 1 to 395 2 to 396   tiling clone, capped   395/395
(100 %)
0 diff
(100 %id)
NM_002137.3   .b 17 to 3682 1 to 3666 exact RefSeq,   3666/3666
(100 %)
0 diff
(100 %id)
DB006541 cervix, tumor tissue .b 18 to 438 2 to 422   capped   421/421
(100 %)
0 diff
(100 %id)
DB244417 uterus, tumor tissue .b 18 to 259 2 to 243   capped   242/242
(100 %)
0 diff
(100 %id)
DA054610 cerebellum .b 28 to 600 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
CN262817 embryonic stem cells, DMSO-treated H9 cellline .b 32 to 551 5 to 524       520/524
(99 %)
6 diff
(98.9 %id)
AU143479   .b 34 to 808 2 to 777   capped   776/776
(100 %)
2 diff
(99.8 %id)
DA541593 lung .b 35 to 392 2 to 359   capped   358/363
(98 %)
1 diff
(99.8 %id)
AU136427 placenta .b 36 to 792 2 to 766   capped   765/768
(99 %)
14 diff
(98.2 %id)
DB145227 thymus .b 36 to 387 2 to 353   capped   352/352
(100 %)
0 diff
(100 %id)
DB246031 uterus, tumor tissue .b 36 to 620 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA116687 cerebellum .b 37 to 628 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DA913775   .b 41 to 603 9 to 571   capped   563/563
(100 %)
0 diff
(100 %id)
DA369333 subthalamic nucleus .b 42 to 538 2 to 498   capped   497/497
(100 %)
0 diff
(100 %id)
DB274785 uterus .b 50 to 273 2 to 225   capped   224/224
(100 %)
0 diff
(100 %id)
AL596816 human spinal cord .b 61 to 666 26 to 631       606/631
(96 %)
6 diff
(99.1 %id)
DB020213 testis .b 62 to 581 2 to 521   capped   520/520
(100 %)
0 diff
(100 %id)
DB120127 thymus .b 62 to 366 2 to 306   capped   305/305
(100 %)
0 diff
(100 %id)
DB237509 trachea .b 62 to 243 2 to 183   capped   182/182
(100 %)
0 diff
(100 %id)
DB244408 uterus, tumor tissue .b 62 to 437 2 to 377   capped   376/376
(100 %)
0 diff
(100 %id)
AK129839 heart .b 63 to 1766 1 to 1704 exact available from FLJ,   1704/1704
(100 %)
1 diff
(100.0 %id)
BP870482 embryonal kidney .b 64 to 395 1 to 332       332/332
(100 %)
0 diff
(100 %id)
BP870729 embryonal kidney .b 64 to 396 1 to 333       333/333
(100 %)
0 diff
(100 %id)
BJ996812 hepatoblastoma .b 64 to 568 1 to 505       505/505
(100 %)
0 diff
(100 %id)
BM830587 Ascites, stomach .b 64 to 565 1 to 502       502/502
(100 %)
0 diff
(100 %id)
AU280828   .b 64 to 624 1 to 561       561/561
(100 %)
0 diff
(100 %id)
DB067911 testis .b 64 to 597 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DA023915   .b 65 to 399 2 to 336   capped   335/335
(100 %)
0 diff
(100 %id)
DA045365 bladder .b 65 to 632 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA053954 cerebellum .b 65 to 816 2 to 753   capped   752/802
(93 %)
10 diff
(98.8 %id)
DA061605 cerebellum .b 65 to 609 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA132137 alzheimer cortex .b 65 to 345 2 to 282   capped   281/281
(100 %)
0 diff
(100 %id)
DA132591 alzheimer cortex .b 65 to 538 2 to 475   capped   474/474
(100 %)
0 diff
(100 %id)
DA185292 amygdala .b 65 to 531 2 to 468   capped   467/467
(100 %)
0 diff
(100 %id)
DA241132 brain .b 65 to 660 2 to 597   capped   596/596
(100 %)
0 diff
(100 %id)
DA372581 thalamus .b 65 to 345 2 to 282   capped   281/281
(100 %)
0 diff
(100 %id)
DA430114 colon .b 65 to 345 2 to 282   capped   281/281
(100 %)
0 diff
(100 %id)
DA493015 brain .b 65 to 613 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA493310 brain .b 65 to 637 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA586030 lung .b 65 to 294 2 to 231   capped   230/230
(100 %)
0 diff
(100 %id)
DA591910 lung .b 65 to 490 2 to 427   capped   426/426
(100 %)
0 diff
(100 %id)
DA597351   .b 65 to 559 2 to 496   capped   495/495
(100 %)
0 diff
(100 %id)
DA605938   .b 65 to 562 2 to 499   capped   498/498
(100 %)
0 diff
(100 %id)
DA607962   .b 65 to 366 2 to 303   capped   302/302
(100 %)
0 diff
(100 %id)
DA611528   .b 65 to 370 2 to 307   capped   306/306
(100 %)
0 diff
(100 %id)
DA612133   .b 65 to 559 2 to 496   capped   495/495
(100 %)
0 diff
(100 %id)
DA617704   .b 65 to 464 2 to 401   capped   400/400
(100 %)
0 diff
(100 %id)
DA618357   .b 65 to 366 2 to 303   capped   302/302
(100 %)
0 diff
(100 %id)
DA644650   .b 65 to 558 2 to 495   capped   494/494
(100 %)
0 diff
(100 %id)
DA701047   .b 65 to 581 2 to 518   capped   517/517
(100 %)
0 diff
(100 %id)
DA703674   .b 65 to 538 2 to 475   capped   474/474
(100 %)
0 diff
(100 %id)
DA728978   .b 65 to 745 2 to 684   capped   683/687
(99 %)
5 diff
(99.3 %id)
DA751516   .b 65 to 534 2 to 471   capped   470/470
(100 %)
0 diff
(100 %id)
DA751969   .b 65 to 555 2 to 492   capped   491/491
(100 %)
0 diff
(100 %id)
DA759335   .b 65 to 628 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
AU134213 ovary, tumor tissue .b 65 to 760 2 to 699   capped   698/698
(100 %)
2 diff
(99.8 %id)
DA814336   .b 65 to 619 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
AU138764 placenta .b 65 to 817 2 to 759   capped   758/841
(90 %)
12 diff
(98.6 %id)
DA838349 placenta .b 65 to 428 2 to 365   capped   364/364
(100 %)
0 diff
(100 %id)
DA863254 placenta .b 65 to 716 2 to 653   capped   652/652
(100 %)
0 diff
(100 %id)
DA874279 Prostate .b 65 to 631 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA890425 rectum .b 65 to 628 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA907457   .b 65 to 625 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA914757   .b 65 to 640 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA916682 small intestine .b 65 to 631 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA969694 stomach .b 65 to 505 2 to 442   capped   441/441
(100 %)
0 diff
(100 %id)
DA976302 synovial membrane tissue from rheumatioidarthritis .b 65 to 567 2 to 504   capped   503/503
(100 %)
0 diff
(100 %id)
DB013181 esophageal, tumor tissue .b 65 to 386 2 to 323   capped   322/322
(100 %)
0 diff
(100 %id)
DB020751 testis .b 65 to 624 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DB071051 testis .b 65 to 596 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DB111078 thymus .b 65 to 539 2 to 476   capped   475/475
(100 %)
0 diff
(100 %id)
DB122010 thymus .b 65 to 628 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB129978 thymus .b 65 to 305 2 to 242   capped   241/241
(100 %)
0 diff
(100 %id)
DB131228 thymus .b 65 to 614 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DB137135 thymus .b 65 to 581 2 to 518   capped   517/517
(100 %)
0 diff
(100 %id)
DB138410 thymus .b 65 to 542 2 to 479   capped   478/478
(100 %)
0 diff
(100 %id)
DB154678 thymus .b 65 to 347 2 to 284   capped   283/283
(100 %)
0 diff
(100 %id)
DB156354 thymus .b 65 to 642 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DB157022 thymus .b 65 to 650 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DB158221 thymus .b 65 to 413 2 to 350   capped   349/349
(100 %)
0 diff
(100 %id)
DB158690 thymus .b 65 to 352 2 to 289   capped   288/288
(100 %)
0 diff
(100 %id)
DB161755 thymus .b 65 to 524 2 to 461   capped   460/460
(100 %)
0 diff
(100 %id)
DB213554 trachea .b 65 to 330 2 to 267   capped   266/266
(100 %)
0 diff
(100 %id)
DB242923 stomach, tumor tissue .b 65 to 624 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DB264385 uterus .b 65 to 395 2 to 332   capped   331/331
(100 %)
0 diff
(100 %id)
DB266330 uterus .b 65 to 464 2 to 401   capped   400/402
(99 %)
1 diff
(99.8 %id)
AU143211   .b 65 to 805 2 to 743   capped   742/742
(100 %)
2 diff
(99.8 %id)
DA397646 thalamus .b 66 to 640 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB104663 thymus .b 66 to 577 2 to 513   capped   512/512
(100 %)
0 diff
(100 %id)
BP872157 embryonal kidney .b 67 to 648 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA138590 alzheimer cortex .b 68 to 386 2 to 320   capped   319/319
(100 %)
0 diff
(100 %id)
DB020312 testis .b 68 to 643 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DB155770 thymus .b 68 to 642 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DN989267 brain, whole brain .b 70 to 656 1 to 587       587/587
(100 %)
5 diff
(99.2 %id)
M29065   .b 78 to 1774 1 to 1697 exact tiling clone,   1697/1700
(99 %)
1 diff
(100.0 %id)
CN262841 embryonic stem cells, DMSO-treated H9 cellline .b 83 to 681 1 to 599       599/599
(100 %)
0 diff
(100 %id)
AU134035 ovary, tumor tissue .b 83 to 762 2 to 681   capped   680/682
(99 %)
2 diff
(99.8 %id)
AA304981 colon .b 89 to 505 1 to 417       417/417
(100 %)
0 diff
(100 %id)
BX395485 Neuroblastoma Cot 50-normalized .b 89 to 931 10 to 852       841/852
(98 %)
7 diff
(99.2 %id)
CN262869 embryonic stem cells, cell lines H1, H7, andH9 .b 93 to 777 1 to 685       685/685
(100 %)
1 diff
(99.9 %id)
CN262849 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 96 to 739 9 to 652       644/652
(98 %)
0 diff
(100 %id)
CX872558 embryonic stem .b 98 to 761 1 to 664       664/664
(100 %)
0 diff
(100 %id)
AW843664 colon_normal .b 128 to 318 191 to 1       191/191
(100 %)
0 diff
(100 %id)
AI284005 esophagus, squamous cell carcinoma .b 148 to 521 374 to 1       374/374
(100 %)
0 diff
(100 %id)
CR982512 T-Lymphocytes .b 154 to 886 1 to 732       732/734
(99 %)
9 diff
(98.8 %id)
CR993887 T-Lymphocytes .b 154 to 924 1 to 773       773/775
(99 %)
6 diff
(99.3 %id)
CR977847 T-Lymphocytes .b 154 to 890 1 to 739       739/741
(99 %)
4 diff
(99.5 %id)
CR993315 T-Lymphocytes .b 154 to 976 1 to 827       827/829
(99 %)
5 diff
(99.4 %id)
CT001601 T-Lymphocytes .b 154 to 474 1 to 321       321/322
(99 %)
1 diff
(99.7 %id)
CR999353 T-Lymphocytes .b 154 to 870 1 to 717       717/717
(100 %)
1 diff
(99.9 %id)
CR990638 T-Lymphocytes .b 154 to 776 1 to 623       623/623
(100 %)
0 diff
(100 %id)
AI904241 breast .b 171 to 305 135 to 1       135/135
(100 %)
0 diff
(100 %id)
CN262807 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 233 to 614 1 to 382       382/382
(100 %)
0 diff
(100 %id)
AU160562   .b 1216 to 1766 552 to 1       552/554
(99 %)
9 diff
(98.4 %id)
BX641084 human testis .c 1 to 5328 1 to 5327 N154T F155T G156L F157A G158L ... tiling clone, available from DKFZ,   5324/5331
(99 %)
11 diff
(99.8 %id)
BI048324 stomach .c 530 to 665 1 to 135       135/135
(100 %)
6 diff
(95.6 %id)
GD160859   .c 4834 to 5293 1 to 63   tiling clone,   63/63
(100 %)
1 diff
(98.5 %id)
BX537494 human amygdala .d 1 to 6275 2 to 6280 exact tiling clone, available from DKFZ, AAA   6280/6280
(100 %)
8 diff
(99.9 %id)
DB290762 uterus .d 36 to 298 2 to 264   capped   263/263
(100 %)
0 diff
(100 %id)
DA920380 small intestine .d 39 to 606 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB157857 thymus .d 39 to 495 2 to 458   capped   457/457
(100 %)
0 diff
(100 %id)
DB276976 uterus .d 39 to 452 2 to 415   capped   414/414
(100 %)
1 diff
(99.8 %id)
DA457991 tongue, tumor tissue .d 42 to 615 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
AA904506 pooled .d 57 to 646 586 to 1       586/586
(100 %)
8 diff
(98.7 %id)
AI832110 colon, colon tumor, RER+ .d 68 to 595 531 to 3       529/534
(99 %)
0 diff
(100 %id)
BF732929 fibrotheoma, ovary .d 208 to 599 392 to 1       392/392
(100 %)
4 diff
(99.0 %id)
BQ323164 colon_est .d 227 to 333 120 to 14       107/120
(89 %)
0 diff
(100 %id)
BE501869 Kidney .d 249 to 626 378 to 1   tiling clone,   378/378
(100 %)
0 diff
(100 %id)
AW449504   .d 310 to 645 336 to 1       336/346
(97 %)
0 diff
(100 %id)
BE831835 marrow .d 497 to 813 15 to 332       318/332
(95 %)
6 diff
(98.2 %id)
BI058833 placenta_normal .d 539 to 886 3 to 350       348/350
(99 %)
6 diff
(98.3 %id)
AI436561 B-cell, chronic lymphotic leukemia .d 696 to 1388 1 to 693   tiling clone, Submitted on the opposite strand 693/696
(99 %)
15 diff
(97.9 %id)
BI019900 marrow .d 723 to 1148 426 to 1       426/426
(100 %)
1 diff
(99.8 %id)
BI018182 marrow .d 764 to 1144 404 to 27       378/404
(93 %)
0 diff
(100 %id)
BI019665 marrow .d 926 to 1156 231 to 1       231/231
(100 %)
3 diff
(98.8 %id)
BX102608 B-cell, chronic lymphotic leukemia .d 957 to 1411 472 to 18     Submitted on the opposite strand 455/472
(96 %)
0 diff
(100 %id)
CV369904 marrow .d 1120 to 1370 40 to 287       248/299
(82 %)
11 diff
(96.4 %id)
CV322379 marrow .d 1153 to 1460 1 to 306       306/306
(100 %)
23 diff
(92.5 %id)
BI020412 marrow .d 1154 to 1485 333 to 3       331/333
(99 %)
0 diff
(100 %id)
AW391616 stomach .d 1206 to 1471 1 to 263       263/278
(94 %)
11 diff
(96.1 %id)
DB290689 uterus .d 1230 to 1824 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
AI064791 Liver .d 1883 to 2450 568 to 1       568/568
(100 %)
1 diff
(99.9 %id)
BG534328 lung .d 2040 to 2646 1 to 635       635/637
(99 %)
28 diff
(95.7 %id)
BG534591 lung .d 2040 to 2793 1 to 753       753/780
(96 %)
18 diff
(97.7 %id)
CB161238 Liver .d 2235 to 2811 1 to 577   tiling clone,   577/577
(100 %)
0 diff
(100 %id)
CK024061 brain/CNS, Human Brain - Frontal Cortex .d 2432 to 3107 1 to 665   tiling clone,   665/674
(98 %)
16 diff
(97.7 %id)
BF923761 nervous_tumor .d 3023 to 3596 623 to 49     Submitted on the opposite strand 575/623
(92 %)
2 diff
(99.7 %id)
CX788796 human embryonic stem cells .d 3502 to 4108 1 to 607       607/607
(100 %)
1 diff
(99.9 %id)
BF342846 brain, glioblastoma with EGFR amplification .d 3525 to 4262 1 to 737       737/738
(99 %)
10 diff
(98.7 %id)
CX872231 embryonic stem .d 3546 to 4118 1 to 573       573/573
(100 %)
2 diff
(99.7 %id)
CN262894 embryonic stem cells, cell lines H1, H7, andH9 .d 3596 to 4239 1 to 644       644/644
(100 %)
2 diff
(99.7 %id)
CN262883 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 3639 to 4238 1 to 600       600/600
(100 %)
4 diff
(99.4 %id)
CN262834 embryonic stem cells, cell lines H1, H7, andH9 .d 3688 to 4188 1 to 501       501/501
(100 %)
0 diff
(100 %id)
BF759012 colon .d 3718 to 4118 6 to 406       401/407
(98 %)
12 diff
(97.1 %id)
BI770526 pooled lung and spleen .d 3765 to 4449 9 to 691       683/692
(98 %)
9 diff
(98.7 %id)
TI_57183432   .d 3765 to 4449 68 to 750       685/751
(91 %)
9 diff
(98.9 %id)
BF902386 marrow .d 3773 to 4189 8 to 427       420/427
(98 %)
21 diff
(95.1 %id)
CN262814 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 3789 to 4533 1 to 745       745/745
(100 %)
5 diff
(99.4 %id)
BG996941 head_neck .d 3827 to 4337 1 to 511       511/511
(100 %)
12 diff
(97.7 %id)
AA134520 colon, tumor .d 3830 to 4328 1 to 499       499/503
(99 %)
6 diff
(98.9 %id)
AA315707 colon .d 3838 to 4294 1 to 457       457/457
(100 %)
0 diff
(100 %id)
CA397716 eye, RPE/choroid .d 3838 to 4412 1 to 575       575/575
(100 %)
0 diff
(100 %id)
BG820600 anaplastic oligodendroglioma with 1p/19qloss, brain .d 3843 to 4553 1 to 711       711/711
(100 %)
16 diff
(97.8 %id)
BI055701 placenta_normal .d 3847 to 4184 351 to 16       336/351
(95 %)
0 diff
(100 %id)
BG820616 anaplastic oligodendroglioma with 1p/19qloss, brain .d 3860 to 4556 1 to 699       699/744
(93 %)
23 diff
(97.0 %id)
CN262833 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 3862 to 4530 1 to 669       669/669
(100 %)
2 diff
(99.8 %id)
BG946570 bladder_tumor .d 3868 to 4195 45 to 370       326/379
(86 %)
20 diff
(94.8 %id)
BF340656 brain, glioblastoma with EGFR amplification .d 3872 to 4677 1 to 801       801/812
(98 %)
34 diff
(95.9 %id)
AA300828 testis .d 3873 to 4185 1 to 313       313/313
(100 %)
1 diff
(99.7 %id)
BI913976 brain .d 3886 to 4555 1 to 671       671/671
(100 %)
10 diff
(98.6 %id)
CX787971 human embryonic stem cells .d 3886 to 4741 1 to 857       857/857
(100 %)
4 diff
(99.6 %id)
TI_57241617   .d 3886 to 4555 30 to 700       671/700
(95 %)
16 diff
(97.8 %id)
EB385738 eye, optic nerve .d 3886 to 4689 1 to 803   tiling clone,   803/803
(100 %)
1 diff
(99.9 %id)
CV575810 cornea, eye .d 3886 to 4449 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
AA361559   .d 3893 to 4213 1 to 321       321/322
(99 %)
1 diff
(99.7 %id)
AA361914   .d 3903 to 4182 1 to 282       282/282
(100 %)
2 diff
(99.3 %id)
BE895898 melanotic melanoma, skin .d 3910 to 4463 1 to 555       555/749
(74 %)
10 diff
(98.7 %id)
DA389399 thalamus .d 3914 to 4490 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
CN262842 embryonic stem cells, DMSO-treated H9 cellline .d 3931 to 4271 1 to 341       341/341
(100 %)
0 diff
(100 %id)
DR763616 embryonic stem .d 3938 to 4689 1 to 751       751/751
(100 %)
1 diff
(99.9 %id)
BG014383 placenta_normal .d 3941 to 4188 12 to 262       249/263
(94 %)
15 diff
(94.3 %id)
CN262847 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 3945 to 4459 9 to 523       515/523
(98 %)
6 diff
(98.9 %id)
CN262871 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 3965 to 4360 11 to 406       396/406
(97 %)
6 diff
(98.6 %id)
CN262818 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 3969 to 4603 9 to 644       636/644
(98 %)
7 diff
(99.0 %id)
CN262828 embryonic stem cells, DMSO-treated H9 cellline .d 3990 to 4699 9 to 718       710/718
(98 %)
8 diff
(98.9 %id)
FN159017 breast carcinoma .d 3990 to 4098 109 to 1     Submitted on the opposite strand 109/111
(98 %)
0 diff
(100 %id)
BM928199 brain .d 4008 to 4686 81 to 765   AAA   685/1151
(59 %)
15 diff
(98.7 %id)
AV746309 Pituitary .d 4024 to 4462 58 to 492       435/546
(79 %)
9 diff
(98.4 %id)
AW360972 colon .d 4049 to 4502 97 to 548       452/552
(81 %)
12 diff
(97.9 %id)
BQ369285 placenta_normal .d 4051 to 4582 1 to 535       535/535
(100 %)
25 diff
(95.4 %id)
AV723925 hypothalamus .d 4051 to 4454 1 to 396       396/397
(99 %)
22 diff
(94.5 %id)
BI752180 brain .d 4052 to 4691 1 to 641       641/641
(100 %)
7 diff
(99.0 %id)
TI_57215132   .d 4052 to 4691 31 to 671       641/671
(95 %)
6 diff
(99.2 %id)
BI598832 brain, hypothalamus .d 4054 to 4815 1 to 764       764/919
(83 %)
23 diff
(97.5 %id)
TI_45213133   .d 4058 to 4815 122 to 881       760/1036
(73 %)
21 diff
(98.0 %id)
DB500982 hypothalamus .d 4059 to 4542 1 to 484       484/484
(100 %)
0 diff
(100 %id)
AA301183 testis .d 4062 to 4228 1 to 167       167/168
(99 %)
2 diff
(98.9 %id)
AA333360 Embryo, 8 weeks .d 4062 to 4363 1 to 307       307/309
(99 %)
6 diff
(98.1 %id)
BG654866 Pancreas, Purified pancreatic islet .d 4062 to 4571 1 to 510       510/510
(100 %)
2 diff
(99.7 %id)
AV725954 hypothalamus .d 4063 to 4740 20 to 695       676/695
(97 %)
17 diff
(97.6 %id)
DW441212 Liver .d 4066 to 4428 17 to 379       363/379
(95 %)
9 diff
(97.7 %id)
AV653683 corresponding non cancerous liver tissue .d 4067 to 4462 1 to 396     Submitted on the opposite strand 396/396
(100 %)
1 diff
(99.8 %id)
D59189   .d 4082 to 4424 1 to 343       343/343
(100 %)
0 diff
(100 %id)
AA331805 Embryo, 8 weeks .d 4083 to 4397 1 to 316       316/316
(100 %)
3 diff
(99.1 %id)
AV752852 Pituitary .d 4084 to 4675 12 to 603       592/641
(92 %)
22 diff
(96.6 %id)
BE825389 lung_normal .d 4089 to 4413 6 to 326       321/326
(98 %)
10 diff
(97.0 %id)
AV745815 Pituitary .d 4096 to 4448 1 to 347       347/354
(98 %)
7 diff
(98.1 %id)
AV746226 Pituitary .d 4097 to 4721 1 to 623       623/624
(99 %)
15 diff
(97.6 %id)
AV746064 Pituitary .d 4098 to 4448 1 to 344       344/354
(97 %)
7 diff
(98.1 %id)
AA334214   .d 4105 to 4417 12 to 325       314/325
(96 %)
6 diff
(98.2 %id)
BF347642 anaplastic oligodendroglioma with 1p/19qloss, brain .d 4108 to 4715 26 to 630       605/631
(95 %)
12 diff
(98.1 %id)
AI690281 carcinoid, lung .d 4116 to 4662 1 to 544     Submitted on the opposite strand 544/555
(98 %)
5 diff
(99.1 %id)
BG115307 duodenal adenocarcinoma, cell line, small intestine .d 4123 to 4768 1 to 643       643/937
(68 %)
17 diff
(98.2 %id)
CN262864 embryonic stem cells, DMSO-treated H9 cellline .d 4125 to 4757 1 to 635       635/635
(100 %)
5 diff
(99.3 %id)
BF344222 brain, glioblastoma with EGFR amplification .d 4126 to 4820 47 to 740       694/851
(81 %)
29 diff
(96.6 %id)
AA311798   .d 4133 to 4404 1 to 272       272/272
(100 %)
0 diff
(100 %id)
N87885   .d 4133 to 4458 1 to 325       325/325
(100 %)
8 diff
(97.6 %id)
AW958629   .d 4134 to 4466 1 to 333       333/333
(100 %)
8 diff
(97.6 %id)
BF177308 blood .d 4139 to 4274 1 to 139       139/140
(99 %)
8 diff
(94.3 %id)
CB999432 Pooled-Skin .d 4140 to 4674 1 to 546       546/886
(61 %)
13 diff
(98.6 %id)
BG622804 placenta .d 4142 to 4855 1 to 715       715/715
(100 %)
20 diff
(97.3 %id)
CD723546 eye, lacrimal gland .d 4149 to 4779 1 to 631       631/631
(100 %)
0 diff
(100 %id)
CD723554 eye, lacrimal gland .d 4149 to 4783 1 to 635       635/635
(100 %)
0 diff
(100 %id)
BX107534 lung .d 4150 to 4843 1 to 696       696/696
(100 %)
2 diff
(99.8 %id)
BF337670 brain, glioblastoma with EGFR amplification .d 4154 to 4942 1 to 785       785/938
(83 %)
32 diff
(96.6 %id)
CB215300 normal endometrium, late proliferativephase, cycle day 13, uterus .d 4155 to 4789 1 to 635       635/635
(100 %)
0 diff
(100 %id)
BQ881292 dorsal root ganglia .d 4155 to 4677 1 to 530       530/886
(59 %)
12 diff
(98.7 %id)
CN262835 embryonic stem cells, DMSO-treated H9 cellline .d 4171 to 4524 1 to 355       355/355
(100 %)
2 diff
(99.5 %id)
BQ718126 sympathetic trunk .d 4173 to 4982 1 to 813       813/872
(93 %)
7 diff
(99.2 %id)
D53769   .d 4183 to 4603 1 to 420       420/423
(99 %)
2 diff
(99.6 %id)
BX645449   .d 4191 to 4861 1 to 671       671/671
(100 %)
0 diff
(100 %id)
CX784772 human embryonic stem cells .d 4200 to 4981 1 to 784       784/784
(100 %)
2 diff
(99.8 %id)
BQ003018 Chondrosarcoma, Left Pelvis .d 4203 to 4740 555 to 19   AAA   537/537
(100 %)
4 diff
(99.3 %id)
AI902984 breast .d 4233 to 4628 1 to 396       396/396
(100 %)
1 diff
(99.8 %id)
AA130568 colon, tumor .d 4651 to 5072 424 to 1       424/437
(97 %)
4 diff
(99.1 %id)
AU133870 ovary, tumor tissue .e 1 to 735 2 to 737   tiling clone, capped   736/739
(99 %)
5 diff
(99.4 %id)
BI223131 cervical carcinoma cell line, cervix .e 617 to 1404 1 to 781       781/791
(98 %)
15 diff
(98.2 %id)
BM423351 amelanotic melanoma, cell line, skin .e 646 to 1345 1 to 700       700/1081
(64 %)
5 diff
(99.6 %id)
BM423851 amelanotic melanoma, cell line, skin .e 646 to 1608 1 to 971   tiling clone,   971/1076
(90 %)
17 diff
(98.5 %id)
BQ880913 dorsal root ganglia .e 710 to 1471 1 to 765       765/908
(84 %)
17 diff
(98.2 %id)
BU183115 melanotic melanoma, skin .e 779 to 1557 1 to 785       785/840
(93 %)
13 diff
(98.5 %id)
CN262840 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 792 to 1502 1 to 714       714/714
(100 %)
8 diff
(98.9 %id)
CN262888 embryonic stem cells, DMSO-treated H9 cellline .e 824 to 1321 13 to 510       501/510
(98 %)
6 diff
(98.9 %id)
AV706678 adrenal gland .e 882 to 1355 1 to 475       475/680
(69 %)
9 diff
(98.7 %id)
BE842784 stomach .e 919 to 1258 92 to 432       341/370
(92 %)
6 diff
(98.4 %id)
CB160979 Liver .e 958 to 1513 1 to 556       556/556
(100 %)
1 diff
(99.9 %id)
AA632567 thyroid .e 965 to 1285 1 to 321       321/321
(100 %)
1 diff
(99.7 %id)
TI_154115820   .e 1000 to 1882 980 to 105   tiling clone, AAA   876/966
(90 %)
23 diff
(97.7 %id)
CN262867 embryonic stem cells, cell lines H1, H7, andH9 .e 1006 to 1543 27 to 564       540/564
(95 %)
6 diff
(99.0 %id)
TI_151771219   .e 1007 to 1552 102 to 647       546/900
(60 %)
4 diff
(99.6 %id)
R07700 liver and spleen .e 1053 to 1422 1 to 374       374/396
(94 %)
8 diff
(98.0 %id)
AI375753   .e 1058 to 1506 451 to 3       449/451
(99 %)
1 diff
(99.8 %id)
AJ715241 bone marrow .e 1070 to 1462 6 to 394       389/394
(98 %)
6 diff
(98.5 %id)
BF982194 duodenal adenocarcinoma, cell line, small intestine .e 1084 to 1503 1 to 419   AAA   419/419
(100 %)
1 diff
(99.8 %id)
AA347509 heart .e 1087 to 1424 1 to 338       338/338
(100 %)
1 diff
(99.8 %id)
CA444713 lung, Metastatic Chondrosarcoma .e 1112 to 1682 590 to 20   AAA   571/577
(98 %)
0 diff
(100 %id)
AA968981 Kidney, kidney tumor .e 1126 to 1506 382 to 2       381/382
(99 %)
0 diff
(100 %id)
AA150159 uterus .e 1127 to 1394 1 to 268   fully sequenced,   268/268
(100 %)
3 diff
(98.9 %id)
FN055456 breast carcinoma .e 1154 to 1255 102 to 1     Submitted on the opposite strand 102/102
(100 %)
1 diff
(99.1 %id)
AA455317 germinal center B cell .e 1173 to 1670 1 to 498       498/498
(100 %)
1 diff
(99.8 %id)
H46858 brain .e 1190 to 1622 1 to 443       443/505
(87 %)
16 diff
(96.9 %id)
AW378387 head_neck .e 1192 to 1555 365 to 2       364/365
(99 %)
2 diff
(99.5 %id)
CB959149 Pooled-Glandular .e 1210 to 1682 1 to 473       473/475
(99 %)
4 diff
(99.2 %id)
DB572162 hypothalamus .e 1218 to 1682 1 to 465     Submitted on the opposite strand 465/465
(100 %)
0 diff
(100 %id)
AA701656 liver and spleen .e 1223 to 1684 462 to 1       462/462
(100 %)
1 diff
(99.8 %id)
AL120931 melanoma (MeWo cell line) .e 1233 to 1687 1 to 455       455/455
(100 %)
0 diff
(100 %id)
AI051123 brain, glioblastoma (pooled) .e 1233 to 1684 452 to 1       452/452
(100 %)
0 diff
(100 %id)
AI624093 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 1235 to 1682 461 to 14   AAA   448/448
(100 %)
0 diff
(100 %id)
H97544 melanocyte .e 1243 to 1682 441 to 1       441/442
(99 %)
3 diff
(99.4 %id)
N33217 melanocyte .e 1246 to 1682 437 to 1       437/437
(100 %)
0 diff
(100 %id)
AW131426 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 1251 to 1682 442 to 11   AAA   432/432
(100 %)
0 diff
(100 %id)
F31071 pectoral muscle (after mastectomy) .e 1251 to 1461 1 to 212       212/212
(100 %)
1 diff
(99.6 %id)
F36516 pectoral muscle (after mastectomy) .e 1251 to 1578 1 to 328       328/328
(100 %)
4 diff
(98.8 %id)
D62527   .e 1253 to 1648 1 to 394       394/394
(100 %)
2 diff
(99.5 %id)
FN156122 breast carcinoma .e 1258 to 1362 1 to 105       105/105
(100 %)
0 diff
(100 %id)
BE348950 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .e 1259 to 1682 424 to 1       424/424
(100 %)
2 diff
(99.6 %id)
AI890992 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 1265 to 1667 403 to 1       403/403
(100 %)
0 diff
(100 %id)
AW193312 adenocarcinoma, Pancreas .e 1265 to 1683 419 to 1       419/419
(100 %)
0 diff
(100 %id)
AA678000 liver and spleen .e 1267 to 1682 414 to 1       414/414
(100 %)
2 diff
(99.6 %id)
AA381275   .e 1276 to 1555 1 to 282       282/293
(96 %)
2 diff
(99.4 %id)
AA381382   .e 1276 to 1595 1 to 321       321/322
(99 %)
4 diff
(98.8 %id)
AA381400   .e 1276 to 1585 1 to 311       311/311
(100 %)
2 diff
(99.4 %id)
AA381460   .e 1276 to 1538 1 to 264       264/265
(99 %)
5 diff
(98.2 %id)
AA381602   .e 1276 to 1559 1 to 285       285/285
(100 %)
2 diff
(99.3 %id)
AA381605   .e 1276 to 1461 1 to 186       186/186
(100 %)
0 diff
(100 %id)
AA381630   .e 1276 to 1561 1 to 286       286/287
(99 %)
1 diff
(99.7 %id)
AA381636   .e 1276 to 1555 1 to 280       280/280
(100 %)
0 diff
(100 %id)
AA381643   .e 1276 to 1543 1 to 268       268/268
(100 %)
0 diff
(100 %id)
AA381644   .e 1276 to 1532 1 to 257       257/257
(100 %)
0 diff
(100 %id)
AA381701   .e 1276 to 1561 1 to 286       286/286
(100 %)
0 diff
(100 %id)
AA381945   .e 1276 to 1532 1 to 257       257/266
(96 %)
1 diff
(99.7 %id)
AI805033 Prostate .e 1278 to 1498 246 to 26   AAA   221/221
(100 %)
3 diff
(98.7 %id)
AI435647 lymph node, lymphoma, follicular mixed small and largecell .e 1279 to 1685 407 to 1       407/407
(100 %)
3 diff
(99.3 %id)
AW168929 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .e 1281 to 1683 404 to 1       404/404
(100 %)
3 diff
(99.3 %id)
BF095218 uterus_tumor .e 1283 to 1674 1 to 392       392/394
(99 %)
1 diff
(99.8 %id)
AA788753 parathyroid gland, parathyroid tumor .e 1288 to 1685 403 to 6       398/403
(98 %)
0 diff
(100 %id)
AA601557 breast .e 1288 to 1685 399 to 2       398/399
(99 %)
0 diff
(100 %id)
AI682609 adenocarcinoma, Pancreas .e 1288 to 1684 397 to 1       397/397
(100 %)
0 diff
(100 %id)
AI298694 carcinoid, lung .e 1290 to 1681 392 to 1       392/392
(100 %)
0 diff
(100 %id)
TI_149283749   .e 1291 to 1873 688 to 105   AAA   584/668
(87 %)
6 diff
(99.2 %id)
BM984167 lung, Primary Lung Epithelial Cells .e 1291 to 1873 599 to 16   AAA   584/584
(100 %)
6 diff
(99.0 %id)
C02214   .e 1298 to 1648 1 to 354       354/355
(99 %)
6 diff
(98.4 %id)
BQ024414 placenta .e 1300 to 1682 401 to 19   AAA   383/383
(100 %)
0 diff
(100 %id)
AW051256 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 1305 to 1505 201 to 1       201/201
(100 %)
0 diff
(100 %id)
AI245176 Kidney .e 1306 to 1682 377 to 1       377/377
(100 %)
0 diff
(100 %id)
AV655359 corresponding non cancerous liver tissue .e 1314 to 1683 1 to 370   AAA Submitted on the opposite strand 370/370
(100 %)
4 diff
(99.0 %id)
AI245198 Kidney .e 1316 to 1682 367 to 1       367/367
(100 %)
0 diff
(100 %id)
AI287545 placenta .e 1316 to 1685 371 to 2       370/371
(99 %)
0 diff
(100 %id)
AI185100 lung .e 1318 to 1668 351 to 1       351/351
(100 %)
2 diff
(99.5 %id)
AA894619 Kidney .e 1321 to 1685 365 to 1       365/365
(100 %)
0 diff
(100 %id)
BE073361 breast .e 1325 to 1563 1 to 239       239/239
(100 %)
1 diff
(99.6 %id)
AW886435 ovary .e 1327 to 1563 1 to 237       237/237
(100 %)
0 diff
(100 %id)
AI272966 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 1336 to 1682 347 to 1       347/347
(100 %)
0 diff
(100 %id)
AA150090 uterus .e 1364 to 1682 319 to 1   fully sequenced,   319/319
(100 %)
0 diff
(100 %id)
BC000506 Lung, small cell carcinoma .f 1 to 1523 1 to 1523 exact tiling clone, available from MGC, AAA   1523/1523
(100 %)
1 diff
(100.0 %id)
TI_1948090537   .f 148 to 747 125 to 735       614/1419
(43 %)
25 diff
(98.3 %id)
AL713513 human skeletal muscle .g 1 to 650 1 to 650 exact tiling clone,   650/650
(100 %)
1 diff
(99.9 %id)
DB278824 uterus .g 257 to 749 2 to 494   capped   493/493
(100 %)
1 diff
(99.8 %id)
BE698422 uterus_tumor .g 558 to 822 1 to 265   tiling clone,   265/265
(100 %)
3 diff
(98.9 %id)
BE698488 uterus_tumor .g 558 to 665 1 to 108       108/108
(100 %)
1 diff
(99.1 %id)
BX484325   .g 719 to 1356 1 to 636   tiling clone,   636/637
(99 %)
5 diff
(99.3 %id)
AW361448 colon .g 735 to 1015 281 to 1       281/281
(100 %)
1 diff
(99.7 %id)
DB090852 testis .g 885 to 1351 2 to 469   tiling clone, capped   468/470
(99 %)
3 diff
(99.4 %id)
DA334062 hippocampus .g 1255 to 1673 2 to 423   tiling clone, capped   422/422
(100 %)
4 diff
(99.1 %id)
BM722434 eye, fetal eye .g 1455 to 1940 134 to 620   tiling clone,   487/620
(78 %)
6 diff
(99.1 %id)
CN481900 eye .g 1456 to 2027 1 to 573       573/573
(100 %)
2 diff
(99.7 %id)
DA146930 amygdala .g 1501 to 1987 2 to 488   capped   487/487
(100 %)
4 diff
(99.2 %id)
BQ876714 sympathetic trunk .g 1554 to 2235 1 to 687       687/835
(82 %)
14 diff
(98.4 %id)
CD723092 eye, lacrimal gland .g 1700 to 2285 1 to 586       586/586
(100 %)
0 diff
(100 %id)
BF734061 amnion_normal .g 1785 to 2045 1 to 262       262/262
(100 %)
3 diff
(98.9 %id)
CB270406 adipose .g 1892 to 2359 468 to 1     Submitted on the opposite strand 468/468
(100 %)
1 diff
(99.8 %id)
DB288023 uterus .g 1897 to 2458 2 to 563   tiling clone, capped   562/562
(100 %)
0 diff
(100 %id)
DA244584 brain .g 1950 to 2549 2 to 601   tiling clone, capped   600/600
(100 %)
0 diff
(100 %id)
BF369045 placenta_normal .g 2424 to 2722 2 to 302       301/302
(99 %)
9 diff
(97.1 %id)
AL597680   .g 2478 to 2933 1 to 456   tiling clone,   456/456
(100 %)
0 diff
(100 %id)
CX785818 human embryonic stem cells .g 2820 to 3632 1 to 813       813/813
(100 %)
0 diff
(100 %id)
CX784717 human embryonic stem cells .g 2841 to 3696 1 to 856       856/856
(100 %)
0 diff
(100 %id)
BX440842 brain, fetal brain .g 2929 to 3884 1 to 951   tiling clone,   951/964
(98 %)
16 diff
(98.4 %id)
GD143060   .g 2946 to 3062 1 to 118       118/131
(90 %)
5 diff
(96.2 %id)
GD153920   .g 3007 to 3177 171 to 1   AAA Submitted on the opposite strand 171/180
(95 %)
2 diff
(98.9 %id)
BM678957 eye, fetal eye .g 3218 to 3927 727 to 19   tiling clone, AAA   709/709
(100 %)
1 diff
(99.9 %id)
BG290346 bladder, transitional cell papilloma, cell line .h 1 to 713 1 to 707 E17* tiling clone,   707/793
(89 %)
15 diff
(98.2 %id)
BG283289 adenocarcinoma, cell line, Prostate .h 208 to 826 1 to 614       614/916
(67 %)
14 diff
(98.5 %id)
BG031973 breast, mammary adenocarcinoma, cell line .h 459 to 1120 1 to 656   tiling clone, AAA   656/656
(100 %)
6 diff
(99.1 %id)
BU943652 mixed (pool of 40 RNAs) .h 482 to 918 1 to 437       437/439
(99 %)
1 diff
(99.8 %id)
BQ001635 lung, Metastatic Chondrosarcoma .h 504 to 1120 636 to 19   tiling clone, AAA   618/625
(98 %)
1 diff
(99.9 %id)
AW378412 head_neck .h 552 to 800 9 to 253       245/253
(96 %)
12 diff
(95.3 %id)
AW378359 head_neck .h 566 to 805 244 to 7       238/244
(97 %)
0 diff
(100 %id)
BG254692 adenocarcinoma, cell line, Prostate .i 1 to 639 1 to 641 G88V G90A Y91T G92E G93V ... tiling clone,   641/870
(73 %)
9 diff
(99.0 %id)
DA350691 substantia nigra .i 60 to 634 2 to 577   capped   576/582
(98 %)
6 diff
(99.0 %id)
BF769882 epid_tumor .i 157 to 630 485 to 11   tiling clone, Submitted on the opposite strand 475/485
(97 %)
0 diff
(100 %id)
BI008034 kidney_tumor .i 325 to 634 13 to 317       305/322
(94 %)
13 diff
(96.0 %id)
AW995519 breast_normal .i 353 to 631 107 to 385   tiling clone,   279/407
(68 %)
7 diff
(98.3 %id)
CR993227 T-Lymphocytes .j 1 to 709 1 to 711 exact tiling clone,   711/711
(100 %)
2 diff
(99.8 %id)
BI962939 Islets of Langerhans, Pancreas .j 122 to 534 1 to 414 exact     414/414
(100 %)
1 diff
(99.8 %id)
BI962867 Islets of Langerhans, Pancreas .j 122 to 538 1 to 417 exact     417/417
(100 %)
0 diff
(100 %id)
AV725852 hypothalamus .k 1 to 724 1 to 724 exact tiling clone, AAA   724/724
(100 %)
12 diff
(98.4 %id)
AV727759 hypothalamus .k 1 to 725 1 to 728 V37C E45X G47S tiling clone, AAA   728/728
(100 %)
29 diff
(96.1 %id)
AV725084 hypothalamus .k 1 to 699 1 to 695 exact     695/697
(99 %)
13 diff
(98.2 %id)
AA614659 breast .k 317 to 725 409 to 1   tiling clone,   409/409
(100 %)
5 diff
(98.8 %id)
AU138999 placenta .l 1 to 734 2 to 735   tiling clone, capped   734/734
(100 %)
6 diff
(99.2 %id)
BX538099 Liver .l 131 to 2197 1 to 2068 exact tiling clone, available from DKFZ, AAA   2068/2068
(100 %)
10 diff
(99.6 %id)
BM722751 eye, fetal eye .l 137 to 799 1 to 663       663/663
(100 %)
0 diff
(100 %id)
AU137570 placenta .l 148 to 794 2 to 652   capped   651/651
(100 %)
3 diff
(99.6 %id)
AA476393   .l 383 to 568 1 to 185       185/185
(100 %)
26 diff
(86.0 %id)
W17235 lung .l 566 to 1026 1 to 455       455/455
(100 %)
6 diff
(98.7 %id)
TI_154046531   .l 932 to 1827 962 to 82 exact AAA   881/1004
(87 %)
61 diff
(94.0 %id)
N40385 melanocyte .l 962 to 1291 1 to 332       332/332
(100 %)
2 diff
(99.4 %id)
AA291227 germinal center B cell .l 973 to 1396 1 to 424       424/424
(100 %)
0 diff
(100 %id)
BF344180 brain, glioblastoma with EGFR amplification .l 988 to 1777 1 to 784 I28H N29*     784/967
(81 %)
20 diff
(98.0 %id)
BG571173 placenta .l 1087 to 1749 1 to 663 K63T     663/663
(100 %)
2 diff
(99.7 %id)
TI_149313497   .l 1097 to 2006 980 to 84 exact AAA   897/992
(90 %)
25 diff
(97.5 %id)
CA412421 Chondrosarcoma Grade II, Left Pelvis .l 1120 to 1827 726 to 19 exact AAA   708/708
(100 %)
3 diff
(99.6 %id)
TI_149289752   .l 1142 to 2006 961 to 109 exact AAA   853/960
(88 %)
24 diff
(97.5 %id)
BG741826 skin .l 1143 to 1854 1 to 713 exact     713/713
(100 %)
1 diff
(99.9 %id)
CN402593 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .l 1146 to 1871 1 to 726 exact     726/726
(100 %)
1 diff
(99.9 %id)
BG741478 skin .l 1170 to 2121 1 to 954 M43H E44G G45R V46C L48A ...     954/958
(99 %)
34 diff
(96.5 %id)
BQ886074 sciatic nerve .l 1185 to 1870 12 to 698 G45S V56G     687/926
(74 %)
20 diff
(97.9 %id)
BG699574 brain, hippocampus .l 1198 to 1822 1 to 626 G40V S41V M43W E44Q available from MGC,   624/628
(99 %)
7 diff
(98.9 %id)
TI_227714867   .l 1202 to 2006 895 to 98 exact AAA   798/971
(82 %)
17 diff
(98.3 %id)
BC045724 Brain, hippocampus .l 1203 to 2006 1 to 804 exact available from MGC, AAA   804/804
(100 %)
0 diff
(100 %id)
N75875 cochlea, ear .l 1206 to 1624 17 to 439   fully sequenced,   423/439
(96 %)
9 diff
(98.0 %id)
TI_149313234   .l 1225 to 2006 858 to 86 exact AAA   773/954
(81 %)
23 diff
(97.6 %id)
TI_149300269   .l 1241 to 2006 841 to 83 exact AAA   759/939
(80 %)
10 diff
(99.0 %id)
TI_154046447   .l 1257 to 2006 842 to 93 A10D T11H T13D V14C C16V ... AAA   750/974
(77 %)
6 diff
(99.4 %id)
CB850822 lung, Primary Lung Cystic Fibrosis EpithelialCells .l 1276 to 2006 747 to 19 exact AAA   729/731
(99 %)
5 diff
(99.4 %id)
CA412352 Chondrosarcoma Grade II, Left Pelvis .l 1279 to 2006 747 to 19 A10D T11H T13D V14C C16V ... AAA   729/729
(100 %)
3 diff
(99.6 %id)
CA413154 Chondrosarcoma Grade II, Left Pelvis .l 1279 to 2006 745 to 19 exact AAA   727/727
(100 %)
1 diff
(99.9 %id)
CB305400 lung, Primary Lung Cystic Fibrosis EpithelialCells .l 1287 to 2006 740 to 19 exact AAA   722/722
(100 %)
5 diff
(99.4 %id)
BQ576091 Chondrosarcoma Grade II, Left Pelvis .l 1300 to 2006 725 to 19 exact AAA   707/707
(100 %)
2 diff
(99.8 %id)
CF541269 lung .l 1328 to 2006 697 to 19 exact AAA   679/679
(100 %)
7 diff
(99.0 %id)
BM688268 eye, human retina .l 1332 to 1820 1 to 489 exact     489/489
(100 %)
4 diff
(99.2 %id)
TI_151699070   .l 1339 to 1830 589 to 98 exact     492/627
(78 %)
2 diff
(99.7 %id)
AW169284 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .l 1361 to 1822 476 to 15 S35P AAA   462/462
(100 %)
1 diff
(99.8 %id)
AI143203 heart .l 1369 to 1830 468 to 7 exact     462/468
(98 %)
0 diff
(100 %id)
CF593586 Human Placenta, placenta .l 1384 to 2006 27 to 650 exact     624/845
(73 %)
10 diff
(98.9 %id)
AI080704 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 1402 to 1827 426 to 1 exact     426/427
(99 %)
0 diff
(100 %id)
TI_151723878   .l 1452 to 2206 851 to 98 N2T S35P AAA   754/759
(99 %)
9 diff
(98.9 %id)
DB376866 placenta .l 1457 to 2006 550 to 2 F17S I18F S19Q T20Q A21L ...     549/558
(98 %)
10 diff
(98.3 %id)
DB379085 placenta .l 1465 to 2006 544 to 1 N2T S8F C16X     544/544
(100 %)
13 diff
(97.7 %id)
AA514269 colon .l 1467 to 1844 1 to 378 exact   Submitted on the opposite strand 378/378
(100 %)
0 diff
(100 %id)
BQ022754 placenta .l 1470 to 1827 371 to 14 exact AAA   358/358
(100 %)
0 diff
(100 %id)
CD365472 Alveolar Macrophage, lung .l 1471 to 2006 555 to 19 exact AAA   537/537
(100 %)
1 diff
(99.9 %id)
BQ575798 Chondrosarcoma Grade II, Left Pelvis .l 1472 to 2206 753 to 19 exact tiling clone, AAA   735/735
(100 %)
2 diff
(99.8 %id)
BM971098 lung .l 1476 to 2006 549 to 19 exact AAA   531/531
(100 %)
0 diff
(100 %id)
BQ024948 placenta .l 1489 to 2006 535 to 19 exact AAA   517/517
(100 %)
1 diff
(99.9 %id)
AA284149 germinal center B cell .l 1512 to 1718 207 to 1       207/207
(100 %)
0 diff
(100 %id)
AA904561 pooled .l 1528 to 1794 1 to 267 exact   Submitted on the opposite strand 267/267
(100 %)
0 diff
(100 %id)
BU740230 eye, fetal eye .l 1541 to 2006 484 to 19 A9D AAA   466/466
(100 %)
1 diff
(99.8 %id)
N27564 melanocyte .l 1564 to 1998 442 to 8       435/443
(98 %)
2 diff
(99.6 %id)
N22090 cochlea, ear .l 1594 to 2006 419 to 1   fully sequenced,   419/419
(100 %)
8 diff
(98.1 %id)
AA476343   .l 1600 to 1830 232 to 2       231/232
(99 %)
0 diff
(100 %id)
N89744 lung .l 1781 to 2206 428 to 1   tiling clone,   428/428
(100 %)
6 diff
(98.6 %id)
BP383925 pancreatic islet .m 1 to 499 499 to 1 exact tiling clone,   499/499
(100 %)
0 diff
(100 %id)
BM454775 leiomyosarcoma, uterus .m 141 to 900 1 to 766       766/1030
(74 %)
15 diff
(98.6 %id)
BQ001067 lung, Metastatic Chondrosarcoma .m 211 to 841 644 to 14   AAA   631/631
(100 %)
0 diff
(100 %id)
AI401617 brain, glioblastoma (pooled) .m 220 to 839 621 to 4       618/622
(99 %)
1 diff
(99.9 %id)
TI_227715800   .m 238 to 1020 862 to 84   tiling clone, AAA   779/992
(78 %)
5 diff
(99.5 %id)
AI359209 brain, glioblastoma (pooled) .m 259 to 836 591 to 1       591/602
(98 %)
21 diff
(96.6 %id)
BG110767 Bone, osteosarcoma, cell line .m 289 to 1018 14 to 739   AAA   726/739
(98 %)
22 diff
(97.1 %id)
BM722247 eye, fetal eye .m 299 to 947 1 to 649   fully sequenced,   649/649
(100 %)
0 diff
(100 %id)
CD366902 Alveolar Macrophage, lung .m 319 to 1020 720 to 19   AAA   702/702
(100 %)
0 diff
(100 %id)
BE856197 brain, glioblastoma (pooled) .m 354 to 831 483 to 6       478/483
(98 %)
3 diff
(99.4 %id)
BU509469 leiomyosarcoma, uterus .m 367 to 1020 1 to 654   AAA   654/654
(100 %)
0 diff
(100 %id)
DN949507 Pancreas, Purified pancreatic islet .m 391 to 781 49 to 439     Submitted on the opposite strand 391/439
(89 %)
6 diff
(98.7 %id)
CA848549 Pancreas, Purified pancreatic islet .m 391 to 1017 11 to 637   fully sequenced,   627/637
(98 %)
6 diff
(99.1 %id)
AI589126 brain, glioblastoma (pooled) .m 419 to 839 424 to 4       421/424
(99 %)
0 diff
(100 %id)
BX454909.
matches multiple genes
brain, fetal brain .m 536 to 1184 665 to 12     also hits gene SEPT4 654/701
(93 %)
15 diff
(97.9 %id)
DN949376.
matches multiple genes
Pancreas, Purified pancreatic islet .m 545 to 1020 491 to 16   AAA Submitted on the opposite strand, also hits gene NPRL3 476/476
(100 %)
0 diff
(100 %id)
BQ632737 Pancreas, Purified pancreatic islet .m 561 to 1221 11 to 671   fully sequenced,   661/671
(98 %)
7 diff
(99.0 %id)
CA449469 Chondrosarcoma, Left Pelvis .m 590 to 1220 650 to 19   AAA   632/632
(100 %)
1 diff
(99.9 %id)
AA403052   .m 625 to 999 1 to 375   fully sequenced,   375/375
(100 %)
0 diff
(100 %id)
BQ632449 Pancreas, Purified pancreatic islet .m 641 to 1221 589 to 9   fully sequenced,   581/589
(98 %)
0 diff
(100 %id)
CA848260 Pancreas, Purified pancreatic islet .m 657 to 1021 365 to 1   fully sequenced,   365/365
(100 %)
0 diff
(100 %id)
AI923848 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .m 690 to 1221 537 to 6       532/537
(99 %)
0 diff
(100 %id)
AI680189 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .m 699 to 1214 516 to 1       516/516
(100 %)
0 diff
(100 %id)
BF058519 fibrotheoma, ovary .m 732 to 1221 495 to 6       490/495
(98 %)
0 diff
(100 %id)
AI472034 pooled .m 763 to 1221 467 to 9       459/467
(98 %)
0 diff
(100 %id)
AI573004 lymph node, lymphoma, follicular mixed small and largecell .m 767 to 1221 457 to 3       455/457
(99 %)
0 diff
(100 %id)
AI355692 lung .m 769 to 1221 453 to 2       452/453
(99 %)
0 diff
(100 %id)
AI355703 lung .m 771 to 1221 451 to 2       450/451
(99 %)
0 diff
(100 %id)
AA687849 normal prostate, Prostate .m 773 to 1212 448 to 9       440/448
(98 %)
0 diff
(100 %id)
N66889 cochlea, ear .m 786 to 1214 437 to 4       434/437
(99 %)
0 diff
(100 %id)
AA757226   .m 787 to 1220 453 to 20   AAA   434/434
(100 %)
0 diff
(100 %id)
AI342620 uterus .m 788 to 1220 443 to 11   AAA   433/433
(100 %)
2 diff
(99.6 %id)
AI298478 carcinoid, lung .m 789 to 1211 449 to 27   AAA   423/423
(100 %)
2 diff
(99.6 %id)
H18598 brain .m 817 to 1220 405 to 1       405/408
(99 %)
6 diff
(98.6 %id)
AW628367 2 pooled high-grade transitional celltumors, genitourinary tract .m 820 to 1212 394 to 2       393/394
(99 %)
0 diff
(100 %id)
BF438901 pooled .m 845 to 1219 375 to 1       375/375
(100 %)
0 diff
(100 %id)
AI075972 pooled .m 878 to 1220 356 to 14   AAA   343/343
(100 %)
1 diff
(99.8 %id)
AI242237 ovary, tumor, 5 pooled (see description) .m 881 to 1221 345 to 5       341/345
(98 %)
0 diff
(100 %id)
R76807 placenta .m 882 to 1193 314 to 1       314/314
(100 %)
2 diff
(99.4 %id)
EL950600 eyeball .m 906 to 1220 1 to 314   AAA   314/314
(100 %)
4 diff
(98.8 %id)
AW002830 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .m 917 to 1220 315 to 12   AAA   304/304
(100 %)
1 diff
(99.7 %id)
BU740103 eye, fetal eye .m 920 to 1444 543 to 19   fully sequenced, AAA   525/525
(100 %)
1 diff
(99.9 %id)
N90151 lung .m 993 to 1221 229 to 1       229/230
(99 %)
1 diff
(99.6 %id)
AA398429   .m 995 to 1447 453 to 1   tiling clone, fully sequenced,   453/453
(100 %)
0 diff
(100 %id)
AI248617 liver and spleen .m 1050 to 1500 451 to 1       451/451
(100 %)
0 diff
(100 %id)
AI248821 liver and spleen .m 1128 to 1500 378 to 6       373/378
(98 %)
0 diff
(100 %id)
CN280908 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .m 1224 to 1890 1 to 667   tiling clone,   667/667
(100 %)
2 diff
(99.8 %id)
AF139791 lung .m 1548 to 1966 1 to 418   tiling clone,   418/427
(97 %)
5 diff
(98.9 %id)
DB218099 trachea .n-u 1 to 493 2 to 494 L5S tiling clone, capped   493/493
(100 %)
1 diff
(99.8 %id)
BI024338 marrow .n-u 222 to 589 410 to 36   tiling clone,   375/410
(91 %)
0 diff
(100 %id)
BF906132 marrow .n-u 284 to 544 262 to 3     Submitted on the opposite strand 260/262
(99 %)
0 diff
(100 %id)
BI019145 marrow .n-u 284 to 522 254 to 16       239/254
(94 %)
0 diff
(100 %id)
CV333358 marrow .n-u 284 to 526 265 to 23     Submitted on the opposite strand 243/265
(91 %)
0 diff
(100 %id)
BM145805 leukopheresis .n-u 512 to 949 453 to 17   tiling clone, AAA   437/442
(98 %)
17 diff
(96.2 %id)
CA433250 mixed .n-u 579 to 869 321 to 32   tiling clone, AAA   290/303
(95 %)
0 diff
(100 %id)
BM148715 leukopheresis .n-u 684 to 949 281 to 17   tiling clone, AAA   265/265
(100 %)
10 diff
(96.3 %id)
DB095097 testis .o-u 1 to 585 2 to 586 exact tiling clone, capped   585/585
(100 %)
0 diff
(100 %id)
FN063289 breast carcinoma .o-u 14 to 101 1 to 89       89/89
(100 %)
3 diff
(96.7 %id)
FN148146 breast carcinoma .o-u 14 to 104 1 to 89       89/89
(100 %)
4 diff
(95.6 %id)
BF769164 epid_tumor .o-u 352 to 862 1 to 512   tiling clone,   512/513
(99 %)
7 diff
(98.7 %id)
BF768409 epid_tumor .o-u 359 to 519 7 to 170       164/174
(94 %)
8 diff
(95.5 %id)
DA227453 brain .p-u 1 to 558 2 to 560 exact tiling clone, capped   559/559
(100 %)
1 diff
(99.9 %id)
BF905366 marrow .p-u 6 to 528 523 to 1 exact   Submitted on the opposite strand 523/523
(100 %)
2 diff
(99.7 %id)
BI019118 marrow .p-u 6 to 454 1 to 451 exact     451/451
(100 %)
1 diff
(99.8 %id)
BI019121 marrow .p-u 6 to 420 1 to 417 exact     417/417
(100 %)
1 diff
(99.8 %id)
AW452459   .p-u 20 to 482 1 to 463 exact   Submitted on the opposite strand 463/463
(100 %)
1 diff
(99.8 %id)
GD146373   .p-u 33 to 106 1 to 75   AAA   75/75
(100 %)
3 diff
(96.0 %id)
GD146396   .p-u 33 to 233 1 to 201   AAA   201/201
(100 %)
3 diff
(98.6 %id)
BF905577 marrow .p-u 52 to 271 220 to 2     Submitted on the opposite strand 219/220
(99 %)
0 diff
(100 %id)
BI018349 marrow .p-u 52 to 283 232 to 1       232/232
(100 %)
0 diff
(100 %id)
BI021394 marrow .p-u 52 to 536 504 to 20 exact     485/504
(96 %)
0 diff
(100 %id)
DA242200 brain .p-u 73 to 615 2 to 544 exact tiling clone, capped   543/543
(100 %)
2 diff
(99.7 %id)
BI021392 marrow .p-u 75 to 539 465 to 1 exact     465/465
(100 %)
4 diff
(99.2 %id)
AA837314 germinal center B cell .p-u 76 to 445 1 to 369 T45Q K46R K47N P48H Y50M ...     369/369
(100 %)
1 diff
(99.8 %id)
AI439014 B-cell, chronic lymphotic leukemia .p-u 76 to 481 1 to 406 exact   Submitted on the opposite strand 406/406
(100 %)
0 diff
(100 %id)
AI911721 pooled .p-u 76 to 498 1 to 423 exact   Submitted on the opposite strand 423/423
(100 %)
0 diff
(100 %id)
AI797452 pooled .p-u 76 to 482 1 to 407 P20X   Submitted on the opposite strand 407/407
(100 %)
3 diff
(99.3 %id)
AI989607 pooled germ cell tumors .p-u 76 to 490 1 to 415 exact   Submitted on the opposite strand 415/419
(99 %)
3 diff
(99.3 %id)
AW104421 pooled .p-u 76 to 506 1 to 431 exact   Submitted on the opposite strand 431/431
(100 %)
0 diff
(100 %id)
BF448637 fibrotheoma, ovary .p-u 76 to 468 1 to 393 G21V L22C R23X A24P R25G ...   Submitted on the opposite strand 393/393
(100 %)
4 diff
(99.0 %id)
AI923367 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .q 1 to 469 469 to 1 exact tiling clone,   469/469
(100 %)
0 diff
(100 %id)
AI583218 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .q 14 to 465 452 to 1 N36S H37L     452/452
(100 %)
3 diff
(99.4 %id)
BX345018   .q 75 to 468 1 to 395       395/395
(100 %)
4 diff
(99.0 %id)
BX427521 fetal liver, Liver .q 75 to 469 1 to 395       395/395
(100 %)
0 diff
(100 %id)
BE815364 breast_normal .r-u 1 to 367 1 to 362 exact tiling clone,   362/362
(100 %)
6 diff
(98.4 %id)
BE815356 breast_normal .r-u 7 to 358 1 to 349 exact     349/349
(100 %)
7 diff
(98.0 %id)
BE815360 breast_normal .r-u 9 to 361 1 to 351 exact tiling clone,   351/351
(100 %)
3 diff
(99.2 %id)
BF960716 nervous_normal .s 1 to 333 12 to 345 exact tiling clone,   334/356
(93 %)
11 diff
(97.0 %id)
BE925249 amnion_normal Gene HNRNPA2B1, variant not shown         This clone was ignored    
CB121161 Liver Gene HNRNPA2B1, variant not shown         This clone was ignored    
368 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n-u, .o-u, .p-u, .q, .r-u, .s Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI